The Bahl Lab
Innovation (IPI) in Boston is recruiting Postdoctoral Fellows. We use
protein design to accelerate drug discovery and to engineer new lead
therapeutic molecules. In addition to traditional academic collaborations,
we work closely with pharmaceutical and biotech companies, as well as
venture capital firms.
We are looking for translationally-minded scientists who want their work to
have a direct impact on the world. We will provide training in
computational protein design using Rosetta, including de novo protein
design and the design of protein function and biophysical properties.
Postdoctoral Fellows at IPI leverage our high-throughput automated
We are especially excited to expand our work in the following research
prediction and design of protein developability for therapeutic
engineering of de novo miniprotein/peptide lead therapeutics for
oncology, infectious disease, hypertension and diabetes, etc.
antibody design, including de novo paratope design
Strong candidates will have demonstrated expertise in one or more of the
protein biochemistry: protein production and biophysical
structural biology: cryo-EM, X-ray crystallography, NMR
immuno-oncology: cell culture models, fluorescence activated cell sorting
traditional protein engineering: directed evolution, library
construction, yeast and/or phage display
computational biology: machine learning, data science, molecular
dynamics and/or modeling
If you are excited to join a team of protein designers working to tackle
audacious projects aimed directly at improving human health, please send
your CV to: firstname.lastname@example.org
The Institute for Protein Innovation is a non-profit organization that is
advancing protein science to accelerate research and improve human health. The
Institute is located at Harvard Medical School. IPI uniquely combines the
freedom of academic exploration with the high-throughput scaling of
industry to take on transformative protein-based initiatives that no other
laboratory or organization can or will pursue. IPI is deploying
state-of-the-art technologies to build a repository of powerful protein
tools and reagents and share them through licensing and collaboration.
These will enable new biomedical and therapeutic discovery for researchers
in academia and industry alike. This constellation of vanguard technology
and expertise positions IPI to train the next generation of entrepreneurs
and protein scientists to lead the discovery of new medicines.
The IPI is an equal opportunity employer and prohibits discrimination based
on ethnicity, religion, sexual orientation, gender identity/expression,
national origin/ancestry, age, disability, socioeconomic status, marital or
veteran status, etc. Candidates from underrepresented backgrounds are
especially encouraged to apply.